JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Reduction mammaplasty with the inferior pedicle technique: early and late complications in 371 patients.

A review of reduction mammaplasties with the inferior pedicle technique in 371 patients over 10 years is presented and the complications associated with this particular technique are discussed. The mean age was 33.1 years (range 15-67), the average preoperative sternal notch to nipple distance was 30.4 cm (range 21-43), the mean breast tissue resected was 870 g per breast (range 250-1960) and the mean operating time was 3.1 hours (range 2.5-4). The overall complication rate was 11.4%. The incidence of specific complications in our series was: haematoma 0.3%, nipple and/or pedicle necrosis 0.8%, wound dehiscence 4.6%, fat necrosis 0.8%, carcinoma 0.5%, loss of sensitivity of the nipple 1.3%, hypertrophic scars 3.3%, dermoid cysts 0.3% and marked lower fullness 0.3%. 72% of the patients that became pregnant were able to lactate.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app